High Point Advisor Group LLC Gilead Sciences, Inc. Transaction History

High Point Advisor Group LLC

$1.4 Billion
Q1 2024

A detailed history of High Point Advisor Group LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, High Point Advisor Group LLC holds 19,212 shares of GILD stock, worth $1.31 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

19,212

Previous 17,818 7.82%

Holding current value

$1.31 Million

Previous $1.44 Million 2.49%

% of portfolio

0.1%

Previous 0.11%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $99,782 - $121,682	1,394 Added 7.82%	19,212 $1.41 Million
Q4 2023 Mar 26, 2024	BUY	$73.27 - $83.09 $128,588 - $145,822	1,755 Added 10.93%	17,818 $1.44 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $106,493 - $119,943	1,845 Added 12.98%	16,063 $1.01 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $25,992 - $28,043	384 Added 2.78%	14,218 $993,000
Q2 2021 Jul 29, 2021	BUY	$63.47 - $69.35 $233,569 - $255,207	3,680 Added 36.24%	13,834 $953,000

Q1 2021 Apr 12, 2021	BUY	$60.0 - $68.46 $31,380 - $35,804	523 Added 5.43%	10,154 $661,000
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $545,596 - $621,681	9,631 New	9,631 $648,000
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $220,353 - $242,381	-3,576 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$61.87 - $69.38 $500,342 - $561,076	-8,087 Reduced 69.34%	3,576 $137,000
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $21,760 - $24,377	-348 Reduced 2.9%	11,663 $774,000
Q4 2018 Feb 20, 2019	SELL	$60.54 - $79.0 $5,509 - $7,189	-91 Reduced 0.75%	12,011 $801,000
Q3 2018 Oct 24, 2018	SELL	$71.28 - $78.92 $15,040 - $16,652	-211 Reduced 1.71%	12,102 $875,000
Q2 2018 Aug 20, 2018	BUY	$64.88 - $75.68 $4,282 - $4,994	66 Added 0.54%	12,313 $931,000
Q1 2018 Jun 11, 2018	SELL	$72.84 - $88.8 $770,938 - $939,859	-10,584 Reduced 46.36%	12,247 $881,000
Q4 2017 Feb 15, 2018	BUY	$71.15 - $83.52 $209,109 - $245,465	2,939 Added 14.77%	22,831 $1.85 Million
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $1.43 Million - $1.7 Million	19,892	19,892 $1.47 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.

Account

High Point Advisor Group LLC Gilead Sciences, Inc. Transaction History